Cargando…
Faecal calprotectin in COVID-19 patients with intestinal symptoms
INTRODUCTION: Extra-pulmonary manifestations of the Coronavirus disease of 2019 (COVID-19) have been increasingly reported, especially gastrointestinal and hepatic system dysfunction. The concern of faecal-oral transmission for COVID-19 was raised. AIM: To study the trend of faecal calprotectin in C...
Autores principales: | Ellakany, Walid Ismail, AbdelHady, Ahmed Mohamed, Nassar, Mohamed Wael, Elwafa, Reham Abdel Haleem Abo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743334/ https://www.ncbi.nlm.nih.gov/pubmed/36514448 http://dx.doi.org/10.5114/pg.2022.114685 |
Ejemplares similares
-
Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020) -
Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021) -
Study of Serum Leptin in Well-differentiated Thyroid Carcinoma: Correlation with Patient and Tumor Characteristics
por: Rehem, Rania Abdel, et al.
Publicado: (2014) -
Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020) -
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)